According to a report by Reuters on September 25th, executives from Smoore International, Hangsen International Group, and Zinwi Biotech have stated that they are researching nicotine-like chemical substances that could serve as alternatives to nicotine in products such as e-cigarettes. However, the health effects of these chemicals may require "several years" of investigation.
Previously, a chemical substance called 6-methyl nicotine has been manufactured in the laboratory with a chemical structure similar to nicotine, and is already being used in some e-cigarettes in the United States. However, regulatory agencies and researchers warn that it may be more potent and addictive than nicotine itself.
E-cigarette-liquid manufacturers Hangsen International Group, Zinwi Biotech, and Smoore International all stated that more research is needed to determine the safety of these chemicals.
Eve Wang, Executive Director of Smoore International, said in an interview with Reuters on Wednesday (25th) that...
“Smoore will not act hastily.”
She stated that a small team at Smoore International is researching these chemical substances called nicotine analogues to understand how they work and their effects.
We should treat it like a drug, thoroughly understand its health impacts before commercializing it... I believe this will require many years of research.
The director of the Hengxin International Research Institute, Yu Kang, and the global communications manager of Zinwi Bio Technology, Haley Xu, stated that their companies are also researching such chemical substances.
Yu Kang stated at the 2024 Global Tobacco and Nicotine Forum (GTNF) held in Athens, Greece, that
We must be extremely careful and thoroughly evaluate whether and how to use them.
He said that Hengxin International is currently researching approximately 10 types of nicotine analogues, including 6-methyl nicotine.
Haley Xu stated that Zinwi Bio is also researching over 10 similar compounds and will ensure their safety before releasing any nicotine analog products.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
